GlassScriptPhysician profile
Stephen J Roman
NPI 1265400287
$3,279.51
in general payments reported to CMS, 2019-2025
34 companies · $421 in 2025
The $421 reported for 2025 was more than what 75% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $339 · 2021: $157 · 2022: $1,027 · 2023: $278 · 2024: $322 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $621.56 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $570.96 | 2019 | |
| Spr Therapeutics, INC | $550.07 | 2022 | |
| Senseonics, Incorporated | $400.00 | 2025 | Eversense |
| Neuronetics, INC. | $255.75 | 2022 | |
| Medtronic, INC. | $207.46 | 2021-2024 | Intellis Adaptivestim |
| Si-Bone, INC. | $183.98 | 2022-2023 | |
| Abbott Laboratories | $140.28 | 2020-2022 | |
| Nevro Corp. | $112.63 | 2020-2021 | |
| Anika Therapeutics, INC. | $103.95 | 2020 | |
| Surgalign Spine Technologies, INC. | $100.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $71.80 | 2020 | |
| Depuy Synthes Sales INC. | $69.13 | 2022-2023 | Orthovisc |
| Ascensia Diabetes Care US INC. | $68.04 | 2024 | |
| Sonex Health, INC. | $41.91 | 2020 | |
| Fidia Pharma USA INC. | $38.32 | 2020-2023 | Triluron, Hymovis |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $34.83 | 2024-2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $28.61 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $26.95 | 2019-2021 | |
| Lilly USA, LLC | $25.29 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $22.42 | 2023 | Horizant |
| Arteriocyte Medical Systems, INC. | $21.67 | 2024 | Magellan |
| Epimed International, INC | $21.32 | 2024 | Prp |
| Bioventus LLC | $20.79 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.28 | 2022 | |
| Protega Pharmaceutials INC | $16.38 | 2023 | Roxybond |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.29 | 2024 | Xifaxan, Trulance |
| Vertical Pharmaceuticals, LLC | $15.00 | 2019 | |
| Pacira Therapeutics, INC. | $14.89 | 2019 | |
| Avanos Medical | $14.69 | 2023 | Genvisc 850 Sodium Hyaluronate |
| Arbor Pharmaceuticals, INC. | $14.39 | 2021 | |
| Ferring Pharmaceuticals INC. | $14.39 | 2022 | |
| Grt US Holding, INC. | $13.91 | 2021 | |
| Scilex Pharmaceuticals INC. | $12.96 | 2020 | |
| Assertio Therapeutics, INC. | $12.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Roman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.